Article Information
PubMed
Print ISSN
Online ISSN
History
- Received July 13, 2016
- Accepted September 16, 2016
- Published online November 9, 2016.
Article Versions
- Earlier version (September 19, 2016 - 10:10).
- You are viewing the most recent version of this article.
Copyright & Usage
Copyright © 2016 by The Author(s) This is an open access article distributed under the CC BY Attribution 4.0 International license.
Author Information
- N. Levy-Cooperman,
- G. McIntyre,
- L. Bonifacio,
- M. McDonnell,
- J. M. Davenport,
- P. S. Covington,
- L. S. Dove, and
- E. M. Sellers
- Altreos Research Partners, Inc., Toronto, Ontario, Canada (N.L.-C.); IntelliDev Consulting, LLC, Lansdale, Pennsylvania (G.M.); Lodestar Pharma Consulting, LLC, Durham, North Carolina (L.B.); INC Research Toronto, Inc. Early Phase CRO, Toronto, Ontario, Canada (M.M.); Furiex Pharmaceuticals, Inc., an affiliate of Allergan plc, Parsippany, New Jersey (J.M.D., P.S.C., L.S.D.); DL Global Partners Inc. and University of Toronto, Toronto, Ontario, Canada (E.M.S.)
- Address correspondence to:
Dr. Naama Levy-Cooperman, Altreos Research Partners, Inc. 50 Wanda Road, Toronto, Ontario, M6P 1C6, Canada. E-mail: nlevy-cooperman{at}altreos.com
Statistics from Altmetric.com
Article usage
In this issue
Abuse Potential of Eluxadoline
